Website profile

Geneonline News

GeneOnline is a premium biotechnology platform providing the latest news on global biotech market trends and research breakthroughs.

  • 226articles · 30d
  • 2+ day agolatest article
  • Aug 14, 2026earliest in window
  • 86%with images
  • 241avg words
articles per day
Categories
  • Medical 79
  • Economy, Business & Finance 75
  • Health & Wellness 55
  • Health 48
  • Finance & Business 40
  • Science & Technology 38
  • News 37
  • Beauty & Fitness 22

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Google News
geneonline.com > sanofi-partners-with-usa-pickleball-to-promote-nuvaxovid-vaccine-to-older-adults

Sanofi Partners With USA Pickleball to Promote Nuvaxovid Vaccine to Older Adults - GeneOnline News

2+ day, 12+ hour ago   (138+ words) Sanofi Partners With USA Pickleball to Promote Nuvaxovid Vaccine to Older Adults geneonline.com Sanofi Partners With USA Pickleball to Promote Nuvaxovid Vaccine to Older Adults Sanofi launched a new educational campaign titled “Serve Up Protection” on September 9, 2026, to provide…...

GeneOnline News
geneonline.com > elevated-cortisol-levels-linked-to-reduced-effectiveness-of-glp-1-and-incretin-therapies-in-type-ii-diabetes-patients

Elevated Cortisol Levels Linked to Reduced Effectiveness of GLP-1 and Incretin Therapies in Type II Diabetes Patients

3+ day, 20+ hour ago   (267+ words) Dr. Elena Christofides reports that elevated cortisol levels may interfere with the effectiveness of GLP-1 and incretin therapies in patients with Type II diabetes. Her findings suggest that cortisol dysregulation serves as a potential factor in why some patients fail…...

GeneOnline News
geneonline.com > sincerely-yours-inc-updates-sunny-side-up-mineral-sunscreen-labeling-in-dailymed-database

Sincerely Yours Inc. Updates Sunny Side Up Mineral Sunscreen Labeling in DailyMed Database

1+ week, 1+ day ago   (243+ words) Sincerely Yours Inc. released updated product information for its Sunny Side Up Mineral Sunscreen Broad Spectrum SPF 30 lotion on September 4, 2026. The product utilizes zinc oxide as its primary active ingredient to provide broad-spectrum ultraviolet protection. The manufacturer filed the updated…...

GeneOnline News
geneonline.com > dailymed-updates-product-information-for-ultra-violette-fave-screen-spf-50-lotion

DailyMed Updates Product Information for Ultra Violette Fave Screen SPF 50 Lotion

1+ week, 3+ day ago   (246+ words) The U.S. National Library of Medicine’s DailyMed database updated its product information for Ultra Violette Fave Screen Broad Spectrum SPF 50 lotion on September 2, 2026. The filing identifies Grace and Fire USA as the distributor for the sunscreen, which utilizes a combination of…...

GeneOnline News
geneonline.com > avespan-llc-updates-product-documentation-for-unpaste-fluoride-tooth-tablets-on-dailymed

Avespan LLC Updates Product Documentation for UNPASTE Fluoride Tooth Tablets on DailyMed

1+ week, 3+ day ago   (252+ words) Avespan LLC has released updated product information for its UNPASTE zero-waste fluoride mint tooth tablets, a chewable dental hygiene product. The updated documentation, filed on September 2, 2026, outlines the specific composition and intended use of the tablets as a fluoride-based oral…...

GeneOnline News
geneonline.com > german-stakeholders-release-consensus-paper-on-reducing-clinical-trial-protocol-amendments

German Stakeholders Release Consensus Paper on Reducing Clinical Trial Protocol Amendments

1+ week, 3+ day ago   (324+ words) A multi-stakeholder group in Germany has released a consensus paper outlining strategies to design early-phase clinical trial protocols that minimize the need for substantial amendments. The report identifies specific approaches to patient cohort selection and protocol structure, aiming to streamline…...

GeneOnline News
geneonline.com > internal-operational-strategies-drive-clinical-trial-start-times-more-than-regulatory-review-periods

Internal Operational Strategies Drive Clinical Trial Start Times More Than Regulatory Review Periods

3+ week, 1+ day ago   (319+ words) Clinical trial timelines vary significantly across the pharmaceutical industry despite uniform regulatory review periods, according to recent industry analysis. Research indicates that internal organizational structures, the use of dedicated trial units, and specific site operational strategies serve as the primary…...

GeneOnline News
geneonline.com > clutch-inc-updates-fda-approved-labeling-for-mineral-based-sunscreen-line

Clutch, Inc. Updates FDA-Approved Labeling for Mineral-Based Sunscreen Line

3+ week, 1+ day ago   (251+ words) Clutch, Inc. updated the product information for its Sweat Resistant Sunscreen Body lotion line on August 21, 2026. The updated documentation covers three specific scent variations—Original, Coconut Vanilla, and Coastal Sandalwood—all of which utilize titanium dioxide and zinc oxide as…...

GeneOnline News
geneonline.com > gingi-pak-updates-gingicaine-gel-variety-pak-regulatory-and-clinical-documentation

Gingi-Pak Updates Gingicaine Gel Variety Pak Regulatory and Clinical Documentation

3+ week, 1+ day ago   (230+ words) Gingi-Pak, a division of Belport, updated the product information for its Gingicaine Gel Variety Pak on August 17, 2026. The update provides current regulatory and clinical data regarding the topical anesthetic gel, which dental professionals use to manage pain during oral procedures....

GeneOnline News
geneonline.com > guangzhou-meixi-biotechnology-updates-apuree-antifungal-cream-labeling-in-dailymed-database

Guangzhou Meixi Biotechnology Updates Apuree Antifungal Cream Labeling in DailyMed Database

3+ week, 1+ day ago   (251+ words) Guangzhou Meixi Biotechnology Co., Ltd. has released updated product information for its Apuree Maximum Strength antifungal cream line, which includes treatments for jock itch, athlete’s foot, and ringworm. The company filed the updated documentation with the National Library of Medicine’s…...